--- title: Access fully human, high affinity antibodies targeting native P2X4 receptor image: https://go.proteogenix.science/hubfs/illustration%20landing%20cld%20audit.png --- [![Boost Your Way to the Clinic! (5)](https://go.proteogenix.science/hs-fs/hubfs/Boost%20Your%20Way%20to%20the%20Clinic!%20(5).png?width=2000&height=709&name=Boost%20Your%20Way%20to%20the%20Clinic!%20(5).png "Boost Your Way to the Clinic! (5)")](https://share-eu1.hsforms.com/1wjO_4x-CQZelAVSoLEzSZQfuwdr) # Why our anti-P2X4 antibodies could be your next lead candidate? At [ProteoGenix](https://www.proteogenix.science/), we’ve partnered with [Cube Biotech](https://cube-biotech.com/) to bring a new breakthrough in therapeutic antibody development: TWO recombinant antibodies targeting P2X4. Fully Human: No Need For Further Humanization ![stable pool](https://go.proteogenix.science/hs-fs/hubfs/stable%20pool.png?width=150&height=150&name=stable%20pool.png "stable pool") High Binding Affinity Confirmed To Native Human P2X4 ![antigen](https://go.proteogenix.science/hs-fs/hubfs/antigen.png?width=150&height=150&name=antigen.png "antigen") High Production Yield & High Purity Validated ![developability study](https://go.proteogenix.science/hs-fs/hubfs/developability%20study.png?width=150&height=150&name=developability%20study.png "developability study") Free Of Intellectual Property ![Design sans titre-1](https://go.proteogenix.science/hs-fs/hubfs/Design%20sans%20titre-1.png?width=150&height=150&name=Design%20sans%20titre-1.png "Design sans titre-1") [![Download documentation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/26635887/interactive-188472023282.png)](https://go.proteogenix.science/hs/cta/wi/redirect?encryptedPayload=AVxigLK2BaBSuV6MpBIfKLLpxtsWIDTcVWPOnR0EHR07ctYNImwcKrl0dbFq9FWfrgC51ZqwpzVwAHqZzJ7rZi3Pm5wRCvnGfEyZGj9vbzkT9vfcm43piMMXrEuMFw%2FfoXPFy%2FWr1mvkIPFwkyBJXvkkgsQbG%2BwAMYAODAIu6MpIZMk%3D&webInteractiveContentId=188472023282&portalId=26635887&hsLang=en) [![Contact us](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/26635887/interactive-188461108443.png)](https://go.proteogenix.science/hs/cta/wi/redirect?encryptedPayload=AVxigLLNKBb9Y7A70%2B00N0qnNypmorQV5wdSPzES2gjmTx4F5069YPR8DYO97pk4a3M%2FnpHXrbRbewDxvIi8GvLb29Hz1WA2IHIQ8uE6WmAF%2Ft4Fcseqyvfa8ceqa2QAl2Xbid8ihl1KRl5F4g9a9LNrmNoKIqX0KSB0hRfH1AEash0WUjgWZ3stpJlrzt%2BkOnIUHjqr%2FJN%2BmuQ8vDB5VD0%3D&webInteractiveContentId=188461108443&portalId=26635887&hsLang=en) # Discover the three breakthrough technologies used to develop anti-P2X4 antibodies NativeMP™ copolymer platform NativeMP™ copolymer platform - Native-like nanodiscs Functional integrity Structural integrity ## [Learn more](https://cube-biotech.com/our-science/nativemp-technology/) Human Phage Display Library Built from PBMCs of 458 diverse donors of 5 different ethnic groups Contain 60 billions different antibodies ## [Learn more](https://www.proteogenix.science/antibody-production/phage-display-services/) Recombinant Antibody Production Proprietary Mammalian Expression System XtenCHO ## [Learn more](https://www.proteogenix.science/product/xtencho-starter-kit/) [![Contact us](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/26635887/interactive-188461108443.png)](https://go.proteogenix.science/hs/cta/wi/redirect?encryptedPayload=AVxigLLNKBb9Y7A70%2B00N0qnNypmorQV5wdSPzES2gjmTx4F5069YPR8DYO97pk4a3M%2FnpHXrbRbewDxvIi8GvLb29Hz1WA2IHIQ8uE6WmAF%2Ft4Fcseqyvfa8ceqa2QAl2Xbid8ihl1KRl5F4g9a9LNrmNoKIqX0KSB0hRfH1AEash0WUjgWZ3stpJlrzt%2BkOnIUHjqr%2FJN%2BmuQ8vDB5VD0%3D&webInteractiveContentId=188461108443&portalId=26635887&hsLang=en) --- --- --- --- [![ft_logo](https://go.proteogenix.science/hubfs/ft_logo.svg)](https://www.proteogenix.science/) © 2026 ProteoGenix | All rights reserved | [Legal notices](https://www.proteogenix.science/legal-notices/)